Choose Language
Select a language for news translation.
Global health foundation Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to support development and initial clinical testing of …
Study results released on Monday revealed that a personalized mRNA vaccine manufactured by Moderna and Merck has shown promise in reducing the return of melano…
Three new vaccines are being developed to tackle the rare species of Ebola that has already killed nearly 250 people. The International Aids Vaccine Initiativ…
A personalized mRNA melanoma vaccine cut recurrence risk to 27.8% vs. 52.8% for placebo over five years. This breakthrough offers a targeted, long-term prevent…
Connie Franciosi, 80, was part of a trial that looked at using an mRNA vaccine and an immunotherapy drug to prevent the recurrence of melanoma. Lynn Winkler hi…
Congo confirmed 282 Ebola cases (264 in Ituri province), with a rare strain having no approved vaccine, worsening due to violence and terrain. Only 45% of cont…
A new Ebola outbreak has killed hundreds—and the U.S. response is alarming experts A deadly Ebola outbreak is spreading fast—and U.S. cuts to foreign aid are …
The Democratic Republic of the Congo and WHO are leading efforts to contain an Ebola outbreak caused by the Bundibugyo virus, which lacks a licensed vaccine or…
AI on the Lot, which has grown from a half-day conference for 600 in 2023 to a two-day draw for nearly 2,500, delivered another dose of techno-optimism this ye…
The World Health Organization (WHO) has hailed the recovery of five people infected with a rare strain of Ebola for which there is no approved vaccine or treat…
A new book looks into the long history of people who have opposed vaccines.
